0000063754-20-000202.txt : 20201202
0000063754-20-000202.hdr.sgml : 20201202
20201202153506
ACCESSION NUMBER: 0000063754-20-000202
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201130
FILED AS OF DATE: 20201202
DATE AS OF CHANGE: 20201202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rimmer Nneka Louise
CENTRAL INDEX KEY: 0001638423
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14920
FILM NUMBER: 201363630
MAIL ADDRESS:
STREET 1: 18 LOVETON CIRCLE
CITY: SPARKS
STATE: MD
ZIP: 21152
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MCCORMICK & CO INC
CENTRAL INDEX KEY: 0000063754
STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS [2090]
IRS NUMBER: 520408290
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1130
BUSINESS ADDRESS:
STREET 1: 24 SCHILLING ROAD
STREET 2: SUITE 1
CITY: HUNT VALLEY
STATE: MD
ZIP: 21031
BUSINESS PHONE: 4107717301
MAIL ADDRESS:
STREET 1: 24 SCHILLING ROAD
STREET 2: SUITE 1
CITY: HUNT VALLEY
STATE: MD
ZIP: 21031
FORMER COMPANY:
FORMER CONFORMED NAME: MCCORMICK & CO
DATE OF NAME CHANGE: 19660620
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-11-30
0000063754
MCCORMICK & CO INC
MKC
0001638423
Rimmer Nneka Louise
MCCORMICK & COMPANY, INCORPORATED
24 SCHILLING ROAD, SUITE 1
HUNT VALLEY
MD
21031
0
1
0
0
President - Global Flavors
and Extracts
Common Stock - Voting
18398
D
Options - Right to Buy
93.49
2020-11-30
4
A
0
85152
0
A
Coimmon Stock - Voting
85152
85152
D
Amounts reported herein reflect the Issuer's 2 for 1 stock split of its common stock and common stock non-voting, effective November 30, 2020.
The option grant vests after the third anniversary date and is only exercisable if certain stock price performance requirements are met. The performance requirements are an increase in the common stock non-voting price of 60% for 1/3 of the options, an increase in the common stock non-voting price of 80% for 1/3 of the options, and an increase in the common stock non-voting price of 100% for 1/3 of the options, in each case within five years of the grant date. Both the vesting date and perfomance requirements must be met for the portion of the grant to become exercisable.
Jason E. Wynn, Attorney-in-fact
2020-12-02